Literature DB >> 17062377

Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia.

W J Schmidt1, R J Beninger.   

Abstract

Incentive learning takes place when dopaminergic neurons are activated, usually by rewards. As a result, previously neutral stimuli associated with reward acquire incentive salience and thus the ability to elicit approach or other responses in the future. Incentive learning is assumed to underlie psychostimulant-induced context-dependent sensitization that may play a prominent role in the development of addiction, in dyskinesia, and in amphetamine-induced psychosis. Assuming that these pathological states are due to the gradual process of sensitization, the effects of therapeutics might be manifested as a gradual desensitization. This assumption could explain the delay between onset of cellular effects of drugs (e.g., dopamine receptor blockade) and the improvement in symptoms (e.g., decreases in psychotic symptoms). Reduced dopamine activity results in behavioural changes that are opposite to psychostimulant-induced sensitization, i.e., rewarded behaviours decline in an extinction-like fashion despite the presence and consumption of rewards. We show here that also non reward-related behaviour, i.e., motor activity and catalepsy, follows the same rules: motility is not switched off by dopamine receptor blockade or by 6-hydroxydopamine lesions, but shows a test-to-test extinction-like decline. Thus, psychostimulant-induced sensitization and dopamine-deficiency induced decline of behaviour follows similar rules but in opposite directions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062377     DOI: 10.1007/bf03033244

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  21 in total

Review 1.  Glutamatergic mechanisms in addiction.

Authors:  T M Tzschentke; W J Schmidt
Journal:  Mol Psychiatry       Date:  2003-04       Impact factor: 15.992

Review 2.  Developments in the drug treatment of schizophrenia.

Authors:  G P Reynolds
Journal:  Trends Pharmacol Sci       Date:  1992-03       Impact factor: 14.819

Review 3.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

Review 4.  Catecholamines in the brain as mediators of amphetamine psychosis.

Authors:  S H Snyder
Journal:  Arch Gen Psychiatry       Date:  1972-08

5.  Major attenuation of food reward with performance-sparing doses of pimozide in the rat.

Authors:  R A Wise; J Spindler; L Legault
Journal:  Can J Psychol       Date:  1978-06

6.  NMDA receptor antagonists do not block the development of sensitization of catalepsy, but make its expression state-dependent.

Authors:  A Lanis; W J Schmidt
Journal:  Behav Pharmacol       Date:  2001-04       Impact factor: 2.293

Review 7.  How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosis.

Authors:  Shitij Kapur
Journal:  Trends Pharmacol Sci       Date:  2004-08       Impact factor: 14.819

Review 8.  Pharmacotherapy of alcohol dependence: a review of the clinical data.

Authors:  Karl Mann
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  The role of dopamine in locomotor activity and learning.

Authors:  R J Beninger
Journal:  Brain Res       Date:  1983-10       Impact factor: 3.252

10.  MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation.

Authors:  W A Carlezon; A Mendrek; R A Wise
Journal:  Synapse       Date:  1995-05       Impact factor: 2.562

View more
  16 in total

1.  Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust.

Authors:  Jocelyn M Richard; Kent C Berridge
Journal:  Eur J Neurosci       Date:  2010-12-29       Impact factor: 3.386

Review 2.  Movement disorders: neurodevelopment and neurobehavioural expression.

Authors:  T Archer; R J Beninger
Journal:  J Neural Transm (Vienna)       Date:  2006-10-06       Impact factor: 3.575

3.  Role of nitric oxide in amphetamine-induced sensitization of schedule-induced polydipsic rats.

Authors:  Yia-Ping Liu; Che-Se Tung; Pai-Jone Lin; Fang-Jung Wan
Journal:  Psychopharmacology (Berl)       Date:  2011-05-28       Impact factor: 4.530

4.  The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.

Authors:  Maurice Y F Shen; Melissa L Perreault; Theresa Fan; Susan R George
Journal:  Pharmacol Biochem Behav       Date:  2014-11-13       Impact factor: 3.533

5.  Basal local cerebral glucose utilization is not altered after behavioral sensitization to quinpirole.

Authors:  Toni L Richards; Thomas L Pazdernik; Beth Levant
Journal:  Neurosci Lett       Date:  2007-10-18       Impact factor: 3.046

6.  Altered dopamine D2 receptor function and binding in obese OLETF rat.

Authors:  Andras Hajnal; Wojciech M Margas; Mihai Covasa
Journal:  Brain Res Bull       Date:  2007-08-08       Impact factor: 4.077

7.  Changes in open-field activity and novelty-seeking behavior in periadolescent rats neonatally treated with monosodium glutamate.

Authors:  P Kiss; D Hauser; A Tamás; A Lubics; B Rácz; Z S Horvath; J Farkas; F Zimmermann; A Stepien; I Lengvari; D Reglódi
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

8.  Mesolimbic dopamine in desire and dread: enabling motivation to be generated by localized glutamate disruptions in nucleus accumbens.

Authors:  Alexis Faure; Sheila M Reynolds; Jocelyn M Richard; Kent C Berridge
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

Review 9.  Dopamine D₃ receptor antagonism--still a therapeutic option for the treatment of schizophrenia.

Authors:  Gerhard Gross; Karsten Wicke; Karla U Drescher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-06       Impact factor: 3.000

10.  The Effects of Non-selective Dopamine Receptor Activation by Apomorphine in the Mouse Hippocampus.

Authors:  Luis Enrique Arroyo-García; Rubén Antonio Vázquez-Roque; Alfonso Díaz; Samuel Treviño; Fidel De La Cruz; Gonzalo Flores; Antonio Rodríguez-Moreno
Journal:  Mol Neurobiol       Date:  2018-03-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.